These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2261778)

  • 21. Effect of peritoneal dialysis on expression of vascular endothelial growth factor, basic fibroblast growth factor and endostatin of the peritoneum in peritoneal dialysis patients.
    Gao D; Zhao ZZ; Liang XH; Li Y; Cao Y; Liu ZS
    Nephrology (Carlton); 2011 Nov; 16(8):736-42. PubMed ID: 21771176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Salvia Miltiorrhiza injection relieves peritoneal dialysis solution-induced injuries of peritoneal structure and function in rats].
    Zhang D; Shu J; Wang Y
    Zhong Xi Yi Jie He Xue Bao; 2008 May; 6(5):517-23. PubMed ID: 18471419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of peritoneal dialysis on the vascular bed of peritoneal membrane.
    van Biesen W; Mortier S; Lameire N; De Vriese A
    Contrib Nephrol; 2006; 150():84-89. PubMed ID: 16720996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Peritoneum as a dialysis membrane. II. Pathology].
    Grzybowski A; Breborowicz A
    Przegl Lek; 1997; 54(1):52-61. PubMed ID: 9190636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Physiology of the peritoneum--a review].
    Haraldsson B
    Lakartidningen; 1990 Apr; 87(17):1479-83. PubMed ID: 2187133
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of the participation of parietal peritoneum in dialysis: physiological, morphological and pharmacological data.
    Knapowski J; Feder E; Simon M; Zabel M
    Proc Eur Dial Transplant Assoc; 1979; 16():155-64. PubMed ID: 548977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual peritoneal volume and body size in children on peritoneal dialysis. [Members of the Mid European Pediatric Peritoneal Dialysis Study Group (MEPPS)].
    Schmitt CP; Dötschmann R; Daschner M; Zimmering M; Greiner C; Böswald M; Klaus G; Schaefer F
    Adv Perit Dial; 1999; 15():287-90. PubMed ID: 10682120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The physiology of peritoneal dialysis.
    Khanna R; Nolph KD
    Am J Nephrol; 1989; 9(6):504-12. PubMed ID: 2688427
    [No Abstract]   [Full Text] [Related]  

  • 29. How does peritoneal dialysis remove small and large molecular weight solutes? Transport pathways: fact and myth.
    Rippe B; Stelin G
    Adv Perit Dial; 1990; 6():13-8. PubMed ID: 1982790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peritoneal thickening is not inevitable in long-term peritoneal dialysis and is associated with peritoneal transport characteristics: a two-centre sonographic study.
    Lee TC; Yang JY; Wang HP; Tsai TJ; Yang Y
    Nephrol Dial Transplant; 2008 Mar; 23(3):1005-10. PubMed ID: 18042613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The quality of the peritoneum in continuous ambulatory peritoneal dialysis].
    Krediet RT; Boeschoten EW; Arisz L
    Ned Tijdschr Geneeskd; 1986 Jan; 130(3):110-3. PubMed ID: 3951598
    [No Abstract]   [Full Text] [Related]  

  • 32. Different aspects of peritoneal damage: fibrosis and sclerosis.
    Garosi G
    Contrib Nephrol; 2009; 163():45-53. PubMed ID: 19494594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.
    Liappas G; González-Mateo G; Aguirre AR; Abensur H; Albar-Vizcaino P; Parra EG; Sandoval P; Ramírez LG; Del Peso G; Acedo JM; Bajo MA; Selgas R; Sánchez Tomero JA; López-Cabrera M; Aguilera A
    Oncotarget; 2016 May; 7(21):30133-46. PubMed ID: 27102153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New developments in peritoneal fibroblast biology: implications for inflammation and fibrosis in peritoneal dialysis.
    Witowski J; Kawka E; Rudolf A; Jörres A
    Biomed Res Int; 2015; 2015():134708. PubMed ID: 26495280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
    Higuchi C; Nishimura H; Sanaka T
    Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous peritoneal mesothelial cell implant in rabbits and peritoneal dialysis patients.
    Di Paolo N; Sacchi G; Vanni L; Corazzi S; Terrana B; Rossi P; Gaggiotti E; Buoncristiani U
    Nephron; 1991; 57(3):323-31. PubMed ID: 2017274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of adhesion molecules in the progression of peritoneal sclerosis.
    Imai H; Nakamoto H; Fukushima R; Ishida Y; Yamanouchi Y; Suzuki H
    Adv Perit Dial; 2003; 19():180-5. PubMed ID: 14763058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GDP and AGE receptors: mechanisms of peritoneal damage.
    Schwenger V
    Contrib Nephrol; 2006; 150():77-83. PubMed ID: 16720995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.